✦ LIBER ✦

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

✍ Scribed by Tsugiko Oze; Naoki Hiramatsu; Nao Kurashige; Natsuko Tsuda; Takayuki Yakushijin; Tatsuya Kanto; Tetsuo Takehara; Akinori Kasahara; Michio Kato; Harumasa Yoshihara; Kazuhiro Katayama; Shinji Kubota; Taizo Hijioka; Kazunobu Ishibashi; Masahide Oshita; Hideki Hagiwara; Yoshimichi Haruna; Eiji Mita; Shinji Tamura; Norio Hayashi

Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 215 KB
Volume: 41
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-006-1858-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Orally administered Kampo medicine, Juze

Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C

✍ Yukihiko Sho; Kunio Fujisaki; Hironori Sakashita; Koichi Yamaguchi; Kenji Tahara 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 156 KB

Pretreatment prediction of anemia progre

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

✍ Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakam 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 264 KB

Immunological predictors of different re

Immunological predictors of different responses to combination therapy with interferon α and ribavirin in patients with chronic hepatitis C

✍ Ravdan Amaraa; Helena Mareckova; Petr Urbanek; Terezie Fucikova 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 215 KB